Kaitlyn D’Onofrio

DocwireNews

Age-related macular degeneration (AMD) is the leading cause of blindness in the word; however, the understanding of the disease&rsquo;s pathogenesis is limited, and there is a lack of accessible and reliable biomarkers for prognosis and diagnosis. Researchers conducted a study to assess and validate plasma metabolomic profiles in patients with AMD and found that patients with AMD have a distinct plasma metabolomic profile compared with patients without AMD, which could signal an easily accessible AMD biomarker. The results of the study were published as part of the American Society of Retina Specialists 2020 Virtual Annual MeetingThis prospective, cross-sectional study was conducted at two sites in Boston, MA, and Coimbra, Portugal. Patients with and without (controls) AMD who were older than 50 years underwent a detailed history, eye exam, color fundus photographs (AMD graded using Age-Related Eye Disease Study classification), and spectral domain-optical coherence tomography. Fasting blood samples were analyzed via ultra-performance liquid chromatography and high-resolution mass spectrometry.The study included 491 patients: 149 with AMD and 47 controls from Boston, MA, and 242 with AMD and 53 controls from Coimbra, Portugal. After excluding 61 exogenous metabolites, analyses were performed on 544 metabolites.After controlling for age, body mass index, smoking status, and gender, the meta-analysis identified 69 significantly different metabolites (P&lt;0.05) between patients with and without AMD, 28 of which had statistically significant false discovery rates. Most of the significant metabolites were lipids (35.7%), followed by amino acids (28.6%), nucleotides (21.4%), carbohydrates (7.1%), cofactors and vitamins (3.6%), and peptides (3.6%).These 28 metabolites belonged to four pathways of significance:&nbsp;purine (P=7.2&times;10-4), sphingolipid (P=0.0010), glycerophospholipid (P=0.0037), and nitrogen metabolites (P=0.0404).&ldquo;These metabolites could provide insight into disease pathogenesis and be the basis for a precision medicine approach leading to effective therapies for early and intermediate AMD,&rdquo; the researchers concluded. &ldquo;Metabolomics offers a potential novel tool for early diagnosis and treatment and may point to new targets for the treatment of macular degeneration.&rdquo;Husain D, Lains I, Miller JB, et al. Role of Metabolomics in Age-Related Macular Degeneration. Presented during the ASRS 2020 Virtual Annual Meeting, July 24-26, 2020.

BMI Modifies the Relationship Between Glycemic Status and Asthma Severity in Children

Asthma

Jordana Jampel

Cutaneous Melanoma: Sun Protection Behaviors and UV Exposure in Canada

Melanoma

Leah Lawrence

Significant Cardiac Benefit Seen With Ifetroban in Patients With Duchenne Muscular Dystrophy

Neurology

Latest News

Plasma Metabolomic Profile May Be a Biomarker for AMD

ASRS 2020

Age-related macular degeneration (AMD) is the leading cause of blindness in the word; however, the understanding of the disease’s pathogenesis is limited, and there is a ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe